CNS Pharmaceuticals (CNSP) Assets (2018 - 2025)
CNS Pharmaceuticals' Assets came in at $8.62 million for Q4 2025, down 0.9% from $8.7 million a year earlier and down 27.3% from the prior quarter.
Powered by 
Analysis
CNS Pharmaceuticals (CNSP) Assets (2018 - 2025) Analysis & Trends
Going back to Q4 2018, CNS Pharmaceuticals' Assets data covers 27 quarters.
- Assets carries a five-year compound annual growth rate of -11.5% (FY2020 to FY2025).
- Going back by year, Assets was $8.7 million in FY2024 (+411.6%), $1.7 million in FY2023 (-87.0%), $13.05 million in FY2022 (+49.1%) and $8.76 million in FY2021 (-44.8%).
- The Q4 2025 figure represents the lowest quarterly Assets since Q3 2024.
- Year-over-year, Assets increased in five of the last eight quarters, with growth averaging 220.6%.
- The fastest year-over-year change in Assets over five years came in Q1 2025 (growth of 727.8%), and the weakest in Q4 2023 (a decline of 87.0%).
- Business Quant data shows CNSP's Assets at $11.87 million (Q3 2025), $14.51 million (Q2 2025) and $13.75 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | CNS Pharmaceuticals | 2.35 Mn | -39.89 Mn | - | 8.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 8.62 Mn |
| Sep 30, 2025 | 11.87 Mn |
| Jun 30, 2025 | 14.51 Mn |
| Mar 31, 2025 | 13.75 Mn |
| Dec 31, 2024 | 8.70 Mn |
| Sep 30, 2024 | 7.41 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Dec 31, 2023 | 1.70 Mn |
| Sep 30, 2023 | 2.33 Mn |
| Jun 30, 2023 | 6.45 Mn |
| Mar 31, 2023 | 7.41 Mn |
| Dec 31, 2022 | 13.05 Mn |
| Sep 30, 2022 | 9.64 Mn |
| Jun 30, 2022 | 12.45 Mn |
| Mar 31, 2022 | 15.87 Mn |
| Dec 31, 2021 | 8.76 Mn |
| Sep 30, 2021 | 11.51 Mn |
| Jun 30, 2021 | 14.24 Mn |
| Mar 31, 2021 | 13.14 Mn |
API Access
CNS Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CNSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CNSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CNSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();